Primary aldosteronism and obstructive sleep apnea: What do we know thus far?
Both primary aldosteronism and obstructive sleep apnea are well-known causes of hypertension and contribute to increased cardiovascular morbidity and mortality independently. However, the relationship between these two entities remains unclear, with studies demonstrating contradictory results. This...
Main Authors: | Huai Heng Loh, Norlela Sukor |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2022.976979/full |
Similar Items
-
Capacities of laboratory diagnosis in the assessment of the activity of the renin-angiotensin-aldosterone system
by: M L Maksimov
Published: (2010-06-01) -
The Effect of Antihypertensive Medications on Testing for Primary Aldosteronism
by: Piotr Jędrusik, et al.
Published: (2021-05-01) -
Obstructive sleep apnea and vitamin D level: Has the dust settled?
by: Huai Heng Loh, et al.
Published: (2024-03-01) -
Effect of calcifediol supplementation on renin‐angiotensin‐aldosterone system mediators in dogs with chronic kidney disease
by: Matthew Miller, et al.
Published: (2022-09-01) -
The Interplay Between the Renin-Angiotensin-Aldosterone System and Parathyroid Hormone
by: Ming-Hui Zheng, et al.
Published: (2020-08-01)